J&J agrees Stelara deals with generics

14-06-2023

Muireann Bolger

J&J agrees Stelara deals with generics

Michael Vi / Shutterstock

Deal thought to be aimed at helping pharma giant attain sales target as patents start to expire | Israeli drugmaker will join with Icelandic firm to unveil a copycat version of blockbuster treatment by 2025.


Stelara, generics, Alvotech, Teva, biosimilar, Crohn's, Amgen,

LSIPR